Sakuranetin Prevents Acetaminophen-Induced Liver Injury via Nrf2-Induced Inhibition of Hepatocyte Ferroptosis
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s497817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Zhida Long und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei, People's Republic of China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Acetaminophen, Ferroptosis, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei, People's Republic of China.
Zitieren
APA
Long, Z., Yu, X., Li, S., Cheng, N., Huo, C., Zhang, X., & Wang, S. (2025). Sakuranetin Prevents Acetaminophen-Induced Liver Injury via Nrf2-Induced Inhibition of Hepatocyte Ferroptosis. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s497817
Vancouver
Long Z, Yu X, Li S, Cheng N, Huo C, Zhang X, et al. Sakuranetin Prevents Acetaminophen-Induced Liver Injury via Nrf2-Induced Inhibition of Hepatocyte Ferroptosis. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s497817
BibTeX
@article{Long2025,
author = {Long, Zhida and Yu, Xiao and Li, Shijia and Cheng, Nuo and Huo, Chenglong and Zhang, Xuewen and Wang, Shuai},
title = {Sakuranetin Prevents Acetaminophen-Induced Liver Injury via Nrf2-Induced Inhibition of Hepatocyte Ferroptosis},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s497817}
}
EUVIMED